Vps34 inhibitors (Sanofi)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameVps34 inhibitors (Sanofi)
Drug Alias Namephosphoinositide 3-kinase subunit 3 inhibitor (Sanofi)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3-kinase catalytic subunit type 3 inhibitors
TargetsPhosphatidylinositol 3-kinase catalytic subunit type 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A